Gastric Ischemic Preconditioning Before Esophagectomy
Short-term Outcomes of Gastric Ischemic Preconditioning Before Esophagectomy With Preoperative Embolization of the Left Gastric Artery: A Prospective Single-Center Study
1 other identifier
observational
20
1 country
1
Brief Summary
The aim of the study is to investigate the impact of left gastric artery embolization before esophagectomy on postoperative complications, particularly anastomotic leaks and necrosis of the gastric conduit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
June 2, 2024
CompletedFirst Posted
Study publicly available on registry
June 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedJune 11, 2024
June 1, 2024
1 year
June 2, 2024
June 6, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Anastomotic leak
6 months
Anastomotic stenosis
6 months
Gastric conduit necrosis
6 months
Study Arms (1)
Patient who underwent Gastric Ischemic Preconditioning Before Esophagectomy
Patient with operable esophageal cancer who underwent embolization of the left gastric artery prior to surgery
Interventions
Does embolization of the left gastric artery prior oesophagectomy reduce postoperative complications, particularly anastomotic leaks and ischemia of the gastric conduit?
Eligibility Criteria
Patient with operable esophageal cancer who underwent embolization of the left gastric artery prior to surgery.
You may qualify if:
- Patient with operable esophageal cancer who underwent embolization of the left gastric artery prior to surgery.
You may not qualify if:
- Patient with no operable esophageal cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Livin
Rennes, Brittany Region, 35000, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chef de Clinique
Study Record Dates
First Submitted
June 2, 2024
First Posted
June 11, 2024
Study Start
June 1, 2024
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
June 11, 2024
Record last verified: 2024-06